JP2008526249A5 - - Google Patents

Info

Publication number

JP2008526249A5

JP2008526249A5 JP2007550872A JP2007550872A JP2008526249A5 JP 2008526249 A5 JP2008526249 A5 JP 2008526249A5 JP 2007550872 A JP2007550872 A JP 2007550872A JP 2007550872 A JP2007550872 A JP 2007550872A JP 2008526249 A5 JP2008526249 A5 JP 2008526249A5

Authority

JP

Japan

Prior art keywords

probe

intensity value

ratios

probes

genetic

Prior art date

2006-01-12

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000523 sample Substances 0.000 claims 96
• 238000000034 method Methods 0.000 claims 54
• 238000012886 linear function Methods 0.000 claims 32
• 230000007614 genetic variation Effects 0.000 claims 30
• 230000035772 mutation Effects 0.000 claims 21
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims 15
• 238000004364 calculation method Methods 0.000 claims 13
• 108020004707 nucleic acids Proteins 0.000 claims 10
• 150000007523 nucleic acids Chemical class 0.000 claims 10
• 102000039446 nucleic acids Human genes 0.000 claims 10
• 239000007787 solid Substances 0.000 claims 10
• 238000004422 calculation algorithm Methods 0.000 claims 9
• 238000003205 genotyping method Methods 0.000 claims 9
• 238000009396 hybridization Methods 0.000 claims 8
• 238000003752 polymerase chain reaction Methods 0.000 claims 8
• 230000003321 amplification Effects 0.000 claims 7
• 238000003199 nucleic acid amplification method Methods 0.000 claims 7
• 108091034117 Oligonucleotide Proteins 0.000 claims 6
• 239000000427 antigen Substances 0.000 claims 5
• 108091007433 antigens Proteins 0.000 claims 5
• 102000036639 antigens Human genes 0.000 claims 5
• 238000004590 computer program Methods 0.000 claims 5
• 210000003743 erythrocyte Anatomy 0.000 claims 5
• 238000000018 DNA microarray Methods 0.000 claims 4
• 108020005187 Oligonucleotide Probes Proteins 0.000 claims 4
• 238000004458 analytical method Methods 0.000 claims 4
• 238000006243 chemical reaction Methods 0.000 claims 4
• 239000002751 oligonucleotide probe Substances 0.000 claims 4
• 238000012408 PCR amplification Methods 0.000 claims 3
• 238000005457 optimization Methods 0.000 claims 3
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 2
• 239000013642 negative control Substances 0.000 claims 2
• 239000002773 nucleotide Substances 0.000 claims 2
• 125000003729 nucleotide group Chemical group 0.000 claims 2
• 238000009827 uniform distribution Methods 0.000 claims 2
• 238000009007 Diagnostic Kit Methods 0.000 claims 1
• 206010061818 Disease progression Diseases 0.000 claims 1
• 238000003556 assay Methods 0.000 claims 1
• 239000012472 biological sample Substances 0.000 claims 1
• 210000004369 blood Anatomy 0.000 claims 1
• 239000008280 blood Substances 0.000 claims 1
• 239000002299 complementary DNA Substances 0.000 claims 1
• 238000000205 computational method Methods 0.000 claims 1
• 238000001514 detection method Methods 0.000 claims 1
• 230000005750 disease progression Effects 0.000 claims 1
• 239000003814 drug Substances 0.000 claims 1
• 239000007850 fluorescent dye Substances 0.000 claims 1
• 238000013467 fragmentation Methods 0.000 claims 1
• 238000006062 fragmentation reaction Methods 0.000 claims 1
• 230000002068 genetic effect Effects 0.000 claims 1
• 239000011521 glass Substances 0.000 claims 1
• 238000000338 in vitro Methods 0.000 claims 1
• 238000002372 labelling Methods 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 claims 1
• 238000011477 surgical intervention Methods 0.000 claims 1
• 230000001225 therapeutic effect Effects 0.000 claims 1
• 238000002560 therapeutic procedure Methods 0.000 claims 1